Science
Column: Paper boosting stem cell firm’s treatments is retracted – Yahoo Finance
A paper co-authored by an executive of a stem cell firm already under FDA fire has been retracted.
The markets lately are a mix of gains and volatility, and its tough, sometimes, for investors to make sense of it. In times like these, it makes sense to turn to the experts. Cathie Wood is one such expert, an investor whose stock choices have consistently outperformed the overall markets. A protégé of famed economist Arthur Laffer, market guru Wood has built her reputation on her clear view of the markets. Her firm is Ark Invest, whose Innovation ETF has over $52 billion in assets under management,…
-
General20 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Noosa News6 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business11 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General22 hours agoFears for next anti-Semitic firebombing on home soil